| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Comparative Carcinogenesis [L. E. B., L. M. A.], Biological Carcinogenesis and Development Program [L. W. F., B. A. D.], and Pathology Histotechnology Laboratory [M. R. A.], Science Applications International Corporation Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, Maryland 21702-1201
To investigate the hypothesis that tumor promotion by chlorinated aromatic hydrocarbons involves Ah receptor occupation and subsequent induction of cytochromes P-450 1a-1, effects of Aroclor 1254 or 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) were examined in N-nitrosodiethyl-amine-initiated mice with different Ah receptor phenotype. Levels of cytochromes P-450 1a and 2b were measured by enzyme assay and Western immunoblots. Males of the C57BL/6, DBA/2, or (C57BL/6 x DBA/2)F1 (hereafter referred to as "B6D2F1") strain were initiated with a single i.p. dose of N-nitrosodiethylamine (90 mg/kg body weight), followed by either multiple doses of TCDD (0.05 µg/kg) weekly or Aroclor 1254 chronically in the diet (100 ppm) for 20 weeks, and then no treatment for 24 weeks. Lung tumor incidence or multiplicity was not altered by either of the promoters. Liver tumor incidence was similar among the three strains after N-nitrosodiethylamine alone (14, 21, and 21%, respectively). In DBA/2 mice, TCDD neither induced Cyp 1a nor promoted liver tumors. Aroclor caused an 8-fold induction of hepatic Cyp 2b, which was its maximum at the 12-week time point but did not promote tumors. Inductions of hepatic Cyp 1a by TCDD and 1a and 2b by Aroclor were similar in C57BL/6 and B6D2F1 mice, but tumor promotion responses were quite different. Dietary Arclor significantly promoted liver tumors in C57BL/6 mice (59 versus 14%) but not in B6D2F1 mice (24 versus 21%). Repeated TCDD promoted only in B6D2F1 mice (52 versus 21%) and not in C57BL/6 mice (19 versus 14%). Thus, whereas these data confirm that a functional Ah receptor is required for liver tumor promotion, the degree of activation as measured by induction of Cyp 1a is not directly related to the degree of tumor-promoting capability. Other genetic factors must play a role in mediating the final tumor outcome.
1 To whom requests for reprints should be addressed, at NCI-FCRDC, Building 538, Room 205-E, Frederick, MD 21702-1201.
Received 6/ 2/95. Accepted 9/ 5/95.
This article has been cited by other articles:
![]() |
O. Moennikes, S. Loeppen, A. Buchmann, P. Andersson, C. Ittrich, L. Poellinger, and M. Schwarz A Constitutively Active Dioxin/Aryl Hydrocarbon Receptor Promotes Hepatocarcinogenesis in Mice Cancer Res., July 15, 2004; 64(14): 4707 - 4710. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Umemura, Y. Kodama, K. Kanki, M. J. Iatropoulos, A. Nishikawa, M. Hirose, and G. M. Williams Pentachlorophenol (but not Phenobarbital) Promotes Intrahepatic Biliary Cysts Induced by Diethylnitrosamine to Cholangio Cystic Neoplasms in B6C3F1 Mice Possibly Due to Oxidative Stress Toxicol Pathol, January 1, 2003; 31(1): 10 - 13. [Abstract] [PDF] |
||||
![]() |
M. Viluksela, Y. Bager, J. T. Tuomisto, G. Scheu, M. Unkila, R. Pohjanvirta, S. Flodström, V.-M. Kosma, J. Mäki-Paakkanen, T. Vartiainen, et al. Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant Rat Strains Cancer Res., December 1, 2000; 60(24): 6911 - 6920. [Abstract] [Full Text] |
||||
![]() |
A. M. Tritscher, J. Mahler, C. J. Portier, G. W. Lucier, and N. J. Walker Induction of Lung Lesions in Female Rats Following Chronic Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicol Pathol, November 1, 2000; 28(6): 761 - 769. [Abstract] [PDF] |
||||
![]() |
T. S. Thurmond and T. A. Gasiewicz A Single Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Produces a Time- and Dose-Dependent Alteration in the Murine Bone Marrow B-Lymphocyte Maturation Profile Toxicol. Sci., November 1, 2000; 58(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |